The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Characterization of Reproductive, Metabolic, and Endocrine Features of Polycystic Ovary Syndrome in Female Hyperandrogenic Mouse Models
Abstract
Polycystic ovary syndrome (PCOS) affects 5–10% of women of reproductive age, causing a range of reproductive, metabolic and endocrine defects including anovulation, infertility, hyperandrogenism, obesity, hyperinsulinism, and an increased risk of type 2 diabetes and cardiovascular disease. Hyperandrogenism is the most consistent feature of PCOS, but its etiology remains unknown, and ethical and logistic constraints limit definitive experimentation in humans to determine mechanisms involved. In this study, we provide the first comprehensive characterization of reproductive, endocrine, and metabolic PCOS traits in 4 distinct murine models of hyperandrogenism, comprising prenatal dihydrotestosterone (DHT, potent nonaromatizable androgen) treatment during days 16–18 of gestation, or long-term treatment (90 days from 21 days of age) with DHT, dehydroepiandrosterone (DHEA), or letrozole (aromatase inhibitor). Prenatal DHT-treated mature mice exhibited irregular estrous cycles, oligo-ovulation, reduced preantral follicle health, hepatic steatosis, and adipocyte hypertrophy, but lacked overall changes in body-fat composition. Long-term DHT treatment induced polycystic ovaries displaying unhealthy antral follicles (degenerate oocyte and/or > 10% pyknotic granulosa cells), as well as anovulation and acyclicity in mature (16-week-old) females. Long-term DHT also increased body and fat pad weights and induced adipocyte hypertrophy and hypercholesterolemia. Long-term letrozole-treated mice exhibited absent or irregular cycles, oligo-ovulation, polycystic ovaries containing hemorrhagic cysts atypical of PCOS, and displayed no metabolic features of PCOS. Long-term dehydroepiandrosterone treatment produced no PCOS features in mature mice. Our findings reveal that long-term DHT treatment replicated a breadth of ovarian, endocrine, and metabolic features of human PCOS and provides the best mouse model for experimental studies of PCOS pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791 · cited 1×
“The presence of steatosis was microscopically quantified blindly by 2 independent investigators by classification into 4 different categories (0 nonfatty liver; 1 possible early steatosis; 2 moderate steatosis; 3 severe steatosis; as outlined in a previous study (39)).”
Method(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0178 · Cited by 2,143
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.035 · Cited by 2,132 · cited 3×
“Reduced corpora lutea numbers in some female mice treated prenatally with DHT, and with letrozole, is consistent with ovulatory dysfunction and the wide heterogeneity of ovarian cycling patterns in PCOS (2).”
BackgroundFauser, B. C. J. M., Tarlatzis, B. C., Rebar, R. W., Legro, R. S., Balen, A. H., Lobo, R., Carmina, E., Chang, J., Yildiz, B. O., Laven, J. S. E., et al. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.09.024 · Cited by 1,976 · cited 3×
“Polycystic ovary syndrome (PCOS) affects 5–10% of women of reproductive age (1).”
BackgroundPolycystic ovary syndrome: etiology, pathogenesis and diagnosis
Goodarzi, M. O., Dumesic, D. A., Chazenbalk, G., & Azziz, R. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.217 · Cited by 1,488 · cited 2×
“Nonreproductive metabolic abnormalities are also often present in women with PCOS, including obesity, metabolic syndrome, hyperinsulinemia, insulin resistance, dyslipidemia, and an increased risk of cardiovascular disease and type 2 diabetes (1, 4).”
BackgroundMethods for quantifying follicular numbers within the mouse ovary
Myers, M., Britt, K. L., Wreford, N. G. M., Ebling, F. J. P., & Kerr, J. B. (2004) · Reproduction · doi:10.1530/rep.1.00095 · Cited by 757
Androgens stimulate early stages of follicular growth in the primate ovary
Vendola, K. A., Zhou, J., Adesanya, O. O., Weil, S. J., & Bondy, C. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2081 · Cited by 712
Follicle dynamics and anovulation in polycystic ovary syndrome
Franks, S., Stark, J., & Hardy, K. (2008) · Human Reproduction Update · doi:10.1093/humupd/dmn015 · Cited by 581
Abbott, D. H., Barnett, D. K., Bruns, C. M., & Dumesic, D. A. (2005) · Human Reproduction Update · doi:10.1093/humupd/dmi013 · Cited by 555 · cited 4×
“Prenatal exposure of sheep and nonhuman primates to androgens has provided models that show striking similarities to women with PCOS (3, 5).”
BackgroundInfluentialThe metabolic syndrome and adipocytokines
Matsuzawa, Y. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.04.028 · Cited by 542
A New Rat Model Exhibiting Both Ovarian and Metabolic Characteristics of Polycystic Ovary Syndrome
Mannerås, L., Cajander, S., Holmäng, A., Seleskovic, Z., Lystig, T., Lönn, M., & Stener-Victorin, E. (2007) · Endocrinology · doi:10.1210/en.2007-0168 · Cited by 483
Letrozole-induced polycystic ovaries in the rat: a new model for cystic ovarian disease
Kafali, H., Iriadam, M., Ozardalı, I., & Demir, N. (2004) · Archives of Medical Research · doi:10.1016/j.arcmed.2003.10.005 · Cited by 449
Induction of spermatogenesis by androgens in gonadotropin-deficient (hpg) mice
Singh, J., O’Neill, C. J., & Handelsman, D. J. (1995) · Endocrinology · doi:10.1210/en.136.12.5311 · Cited by 401
Self-citationThe evolving role of inflammation in obesity and the metabolic syndrome
Lee, Y.-H., & Pratley, R. E. (2005) · Current Diabetes Reports · doi:10.1007/s11892-005-0071-7 · Cited by 369
Rodent Models for Human Polycystic Ovary Syndrome1
Walters, K. A., Allan, C. M., & Handelsman, D. J. (2012) · Biology of Reproduction · doi:10.1095/biolreprod.111.097808 · Cited by 313
Self-citationSullivan, S. D., & Moenter, S. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308058101 · Cited by 308
Development of polycystic ovary syndrome: involvement of genetic and environmental factors
FRANKS, S., MCCARTHY, M. I., & HARDY, K. (2006) · International Journal of Andrology · doi:10.1111/j.1365-2605.2005.00623.x · Cited by 306
Harwood, D. T., & Handelsman, D. J. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.09.003 · Cited by 243
Self-citationAn Age-Related Ovarian Phenotype in Mice with Targeted Disruption of the Cyp 19 (Aromatase) Gene
Britt, K. L., Drummond, A. E., Cox, V. A., Dyson, M., Wreford, N. G., Jones, M. E. E., Simpson, E. R., & Findlay, J. K. (2000) · Endocrinology · doi:10.1210/en.141.7.2614 · Cited by 233
Schomberg, D. W., Couse, J. F., Mukherjee, A., Lubahn, D. B., Sar, M., Mayo, K. E., & Korach, K. S. (1999) · Endocrinology · doi:10.1210/endo.140.6.6823 · Cited by 231
Abbott, D. H., Dumesic, D. A., Eisner, J. R., Colman, R. J., & Kemnitz, J. W. (1998) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(98)00019-8 · Cited by 230
Sheep models of polycystic ovary syndrome phenotype
Padmanabhan, V., & Veiga-Lopez, A. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.10.005 · Cited by 225
Effect of androgens on the development of mouse follicles growing in vitro
Murray, A. A., Gosden, R. G., Allison, V, & Spears, N. (1998) · Reproduction · doi:10.1530/jrf.0.1130027 · Cited by 205
Kumar, T. R., Palapattu, G. S., Wang, P., Woodruff, T. K., Boime, I., Byrne, M. C., & Matzuk, M. M. (1999) · Molecular Endocrinology · doi:10.1210/me.13.6.851 · Cited by 194
Osteoblasts mediate the adverse effects of glucocorticoids on fuel metabolism
Brennan-Speranza, T. C., Henneicke, H., Gasparini, S. J., Blankenstein, K. I., Heinevetter, U., Cogger, V. C., Svistounov, D., Zhang, Y., Cooney, G. J., Buttgereit, F., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63377 · Cited by 187
Reproductive and Metabolic Phenotype of a Mouse Model of PCOS
van Houten, E. L. A. F., Kramer, P., McLuskey, A., Karels, B., Themmen, A. P. N., & Visser, J. A. (2012) · Endocrinology · doi:10.1210/en.2011-1754 · Cited by 184
Prenatal androgen exposure programs metabolic dysfunction in female mice
Roland, A. V., Nunemaker, C. S., Keller, S. R., & Moenter, S. M. (2010) · Journal of Endocrinology · doi:10.1677/joe-10-0217 · Cited by 184
Dumesic, D. A., Abbott, D. H., Eisner, J. R., & Goy, R. W. (1997) · Fertility and Sterility · doi:10.1016/s0015-0282(97)81873-0 · Cited by 171
Endocrine Traits of Polycystic Ovary Syndrome in Prenatally Androgenized Female Sprague-Dawley Rats
Wu, X., Li, Z., Cheng-yong, W., Liu, Y., Lin, H., Wang, S., & Xiao, W. (2010) · Endocrine Journal · doi:10.1507/endocrj.k09e-205 · Cited by 162
Walters, K. A., Allan, C. M., Jimenez, M., Lim, P., Davey, R. A., Zajac, J. D., Illingworth, P. J., & Handelsman, D. J. (2007) · Endocrinology · doi:10.1210/en.2007-0248 · Cited by 160
Self-citationPadmanabhan, V., Veiga‐Lopez, A., Abbott, D. H., Recabarren, S. E., & Herkimer, C. (2009) · Endocrinology · doi:10.1210/en.2009-1015 · Cited by 142
Effect of Adrenal and Ovarian Androgens on Type 4 Follicles Unresponsive to FSH in Immature Mice
Wang, H., Andoh, K., Hagiwara, H., Xiaowei, L., Kikuchi, N., Abe, Y., 山田, 清., Fatima, R., & Mizunuma, H. (2001) · Endocrinology · doi:10.1210/endo.142.11.8482 · Cited by 135
Are There Any Sensitive and Specific Sex Steroid Markers for Polycystic Ovary Syndrome?
Stener‐Victorin, E., Holm, G., Labrie, F., Nilsson, L., Janson, P. O., & Ohlsson, C. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1908 · Cited by 135
Manikkam, M., Steckler, T. L., Welch, K. B., Inskeep, E. K., & Padmanabhan, V. (2005) · Endocrinology · doi:10.1210/en.2005-1338 · Cited by 130
van Casteren, J. I. J., Schoonen, W. G. E. J., & Kloosterboer, H. J. (2000) · Biology of Reproduction · doi:10.1095/biolreprod62.4.886 · Cited by 128
Contributions of androgen and estrogen to fetal programming of ovarian dysfunction
Abbott, D. H., Padmanabhan, V., & Dumesic, D. A. (2006) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-4-17 · Cited by 127
Walters, K. A., Middleton, L. J., Joseph, S. R., Hazra, R., Jimenez, M., Simanainen, U., Allan, C. M., & Handelsman, D. J. (2012) · Biology of Reproduction · doi:10.1095/biolreprod.112.102012 · Cited by 125
Self-citationAdipokines in reproductive function: a link between obesity and polycystic ovary syndrome
Chen, X., Jia, X., Qiao, J., Guan, Y., & Kang, J. (2013) · Journal of Molecular Endocrinology · doi:10.1530/jme-12-0247 · Cited by 122
McNamara, K. M., Harwood, D. T., Simanainen, U., Walters, K. A., Jimenez, M., & Handelsman, D. J. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.02.001 · Cited by 119
Self-citationSmith, P. R., Steckler, T. L., Veiga‐Lopez, A., & Padmanabhan, V. (2008) · Biology of Reproduction · doi:10.1095/biolreprod.108.072801 · Cited by 119
Nonhuman primate models of polycystic ovary syndrome
Abbott, D. H., Nicol, L. E., Levine, J. E., Xu, N., Goodarzi, M. O., & Dumesic, D. A. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.01.013 · Cited by 118
Wild, R. A. (2012) · Steroids · doi:10.1016/j.steroids.2011.12.002 · Cited by 117 · cited 1×
“In addition, DHT-treated females exhibited hypercholesterolemia, which is present in women with PCOS, and is a risk factor for cardiovascular disease (58).”
BackgroundIntra-follicular activin availability is altered in prenatally-androgenized lambs
West, C. R., Foster, D. L., Evans, N. P., Robinson, J. E., & Padmanabhan, V. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(01)00632-3 · Cited by 117
Maliqueo, M. A., Sun, M., Johansson, J., Benrick, A., Labrie, F., Svensson, H. G., Lönn, M., Dulęba, A. J., & Stener‐Victorin, E. (2012) · Endocrinology · doi:10.1210/en.2012-1693 · Cited by 115
Roy, S., Mahesh, V. B., & Greenblatt, R. B. (1962) · Nature · doi:10.1038/196042a0 · Cited by 107
Adipocyte biology in polycystic ovary syndrome
Barber, T. M., & Franks, S. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.10.010 · Cited by 104
Effects of dehydroepiandrosterone on ovarian cystogenesis and immune function
Luchetti, C. G., Solano, M. E., Sander, V. A., Arcos, M. L. B., González, C. D., Girolamo, G. D., Chiocchio, S. R., Cremaschi, G., & Motta, A. B. (2004) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2004.04.002 · Cited by 103
Genetic Variables That Influence Phenotype
Linder, C. C. (2006) · ILAR Journal · doi:10.1093/ilar.47.2.132 · Cited by 101
Sander, V. A., Luchetti, C. G., Solano, M. E., Elia, E. M., Girolamo, G. D., González, C. D., & Motta, A. B. (2006) · Reproduction · doi:10.1530/rep.1.00941 · Cited by 100
Hogg, K., Wood, C., McNeilly, A. S., & Duncan, W. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024877 · Cited by 95
Lee, M., Anderson, E., & Lee, G. Y. (1991) · The Anatomical Record · doi:10.1002/ar.1092310206 · Cited by 87
Edwards, D. A. (1971) · Physiology & Behavior · doi:10.1016/0031-9384(71)90030-8 · Cited by 85
Disordered follicle development in ovaries of prenatally androgenized ewes
Forsdike, R. A., Hardy, K., Bull, L., Stark, J., Webber, L. J., Stubbs, S. A., Robinson, J. E., & Franks, S. (2007) · Journal of Endocrinology · doi:10.1677/joe.1.07097 · Cited by 85
Tyndall, V., Broyde, M., Sharpe, R. M., Welsh, M., Drake, A. J., & McNeilly, A. S. (2011) · Reproduction · doi:10.1530/rep-11-0239 · Cited by 82
Franks, S. (2012) · Endocrinology · doi:10.1210/en.2012-1366 · Cited by 64
Prevalence of hepatic steatosis in women with polycystic ovary syndrome
Karoli, R., Fatima, J., Chandra, A., Gupta, U., Islam, F.-U., & Singh, G. (2013) · Journal of Human Reproductive Sciences · doi:10.4103/0974-1208.112370 · Cited by 63
Ward, R. C., Costoff, A., & Mahesh, V. B. (1978) · Biology of Reproduction · doi:10.1095/biolreprod18.4.614 · Cited by 58
Jimenez, M., Spaliviero, J. A., GROOTENHUIS, A. J., Verhagen, J., Allan, C. M., & Handelsman, D. J. (2004) · Biology of Reproduction · doi:10.1095/biolreprod.104.033654 · Cited by 40
Self-citationAndrogen Resistance in Female Mice Increases Susceptibility to DMBA-Induced Mammary Tumors
Simanainen, U., Gao, Y., Walters, K. A., Watson, G., Desai, R., Jimenez, M., & Handelsman, D. J. (2012) · Hormones and Cancer · doi:10.1007/s12672-012-0107-9 · Cited by 27
Self-citationGenetic Factors Modulate the Impact of Pubertal Androgen Excess on Insulin Sensitivity and Fertility
Dowling, A. R., Nedorezov, L., Qiu, X., Marino, J. S., & Hill, J. W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079849 · Cited by 17
Cited by
Animal Models to Understand the Etiology and Pathophysiology of Polycystic Ovary Syndrome
Stener-Victorin, E., Padmanabhan, V., Walters, K. A., Campbell, R. E., Benrick, A., Giacobini, P., Dumesic, D. A., & Abbott, D. H. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa010 · Cited by 348
Self-citationNilsson, M. E., Vandenput, L., Tivesten, Å., Norlén, A.-K., Lagerquist, M. K., Windahl, S. H., Börjesson, A. E., Farman, H. H., Poutanen, M., Benrick, A., et al. (2015) · Endocrinology · doi:10.1210/en.2014-1890 · Cited by 336
New Perspectives on the Pathogenesis of PCOS: Neuroendocrine Origins
Walters, K. A., Gilchrist, R. B., Ledger, W. L., Teede, H. J., Handelsman, D. J., & Campbell, R. E. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2018.08.005 · Cited by 186
Self-citationEstrogen as a key regulator of energy homeostasis and metabolic health
Mahboobifard, F., Pourgholami, M. H., Jorjani, M., Dargahi, L., Amiri, M., Sadeghi, S., & Tehrani, F. R. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113808 · Cited by 154
Androgens and ovarian function: translation from basic discovery research to clinical impact
Walters, K. A., Rodriguez Paris, V, Aflatounian, A., & Handelsman, D. J. (2019) · Journal of Endocrinology · doi:10.1530/joe-19-0096 · Cited by 104
Self-citation
Metadata
- Authors
- Caldwell, A. S. L., Middleton, L. J., Jimenez, M., Desai, R., McMahon, A. C., Allan, C. M., Handelsman, D. J., & Walters, K. A.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2014-08-01
- Volume
- 155
- Issue
- 8
- Pages
- 3146-3159
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2084300141
- Cited by
- 342
- References
- 62
- FWCI
- 16.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.